Physician profile
Mark K Wax
NPI 1912912429
$20,498.97
in general payments reported to CMS, 2019-2025
11 companies · $8,024 in 2025
The $8,024 reported for 2025 was more than what 97% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,250 · 2022: $1,961 · 2023: $1,810 · 2024: $5,454 · 2025: $8,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $1,803 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,575 · Food and Beverage: $1,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,510.00 |
| Travel and Lodging | $1,803.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,575.00 |
| Food and Beverage | $1,399.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $10,510.00 | 2024-2025 | Summit Doppler |
| Cook Incorporated | $5,940.00 | 2021-2023 | Cook-Swartz |
| Medical Device Business Services, INC. | $2,141.55 | 2025 | Trumatch |
| Depuy Synthes Sales INC. | $566.89 | 2021-2025 | Trumatch, Matrixmandible, Matrixmidface |
| Kls-Martin L.P. | $447.04 | 2021-2025 | |
| Baxter Healthcare | $392.62 | 2022-2024 | |
| Polynovo North America LLC | $172.85 | 2022-2023 | |
| Kerecis Limited | $150.81 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Axogen | $100.79 | 2021 | |
| Stryker Corporation | $57.19 | 2022 | |
| Cook Medical LLC | $19.23 | 2023 | Cook-Swartz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wax listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.